|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.266 USD | -5.07% |
|
-7.73% | -46.86% |
| Mar. 26 | ISpecimen Inc. Announces the Board Changes | CI |
| Mar. 14 | Transcript : ISpecimen Inc., 2023 Earnings Call, Mar 14, 2024 |
iSpecimen Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 9.93 million compared to USD 10.4 million a year ago. Net loss was USD 11.1 million compared to USD 10.25 million a year ago.
Basic loss per share from continuing operations was USD 1.23 compared to USD 1.16 a year ago. Diluted loss per share from continuing operations was USD 1.23 compared to USD 1.16 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -46.86% | 2.49M | |
| +8.05% | 3,020B | |
| +5.58% | 82.93B | |
| +3.69% | 76.85B | |
| -14.62% | 53.04B | |
| +31.16% | 50.15B | |
| -24.56% | 46.71B | |
| +17.75% | 41.41B | |
| +55.21% | 36.1B | |
| -10.24% | 24.64B |
ISPECIMEN INC. 
